Escalante, Jocelyn .
HRN: 27-10-54 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/14/2025
CEFTRIAXONE 1G (VIAL)
05/14/2025
05/21/2025
IV
2 Gram
OD
Abdominal Infections
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes